5,10-dihydro-5-methylphenazine has been researched along with Bipolar Disorder in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, I; Hong, SD; Joung, YS; Song, M; Yoon, H | 1 |
1 other study(ies) available for 5,10-dihydro-5-methylphenazine and Bipolar Disorder
| Article | Year |
|---|---|
Differences of clinical characteristics and phenotypes between prepubertal- and adolescent-onset bipolar disorders.
Topics: Adolescent; Age of Onset; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Child; Comorbidity; Female; Humans; Male; Phenazines; Phenotype; Retrospective Studies | 2010 |